VAC14 Antikörper (AA 711-760)
Kurzübersicht für VAC14 Antikörper (AA 711-760) (ABIN6755525)
Target
Alle VAC14 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 711-760
-
Marke
- IHC-plus™
-
Spezifität
- Human VAC14
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide located between aa711-760 of human VAC14 (Q08AM6, NP_060522). Percent identity by BLAST analysis: Human, Gorilla, Monkey, Galago, Marmoset, Dog, Bovine (100%), Gibbon, Mouse, Rat, Panda, Horse (92%), Bat (85%).
Type of Immunogen: Synthetic peptide
-
-
-
-
Applikationshinweise
- Approved: IHC, IHC-P (10 μg/mL), WB (1 μg/mL)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Distilled water
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- VAC14 (Vac14 Homolog (VAC14))
-
Andere Bezeichnung
- VAC14 / TRX
-
Hintergrund
-
Name/Gene ID: VAC14
Synonyms: VAC14, ArPIKfyve, Protein VAC14 homolog, TAX1BP2, TRX, Vac14 homolog (S. cerevisiae), Tax1-binding protein 2 -
Gen-ID
- 55697
-
NCBI Accession
- NP_060522
-
Pathways
- Inositol Metabolic Process
Target
-